Park Compounding Recalls Methylcobalamin Injection Due to Sterility Concerns
South Coast Specialty Compounding is recalling Methylcobalamin Injection 5 mg/mL vials due to a lack of assurance of sterility. The affected products were distributed in California and Indiana.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable medication, which poses a significant risk of infection or serious injury.
Plain-English summary
South Coast Specialty Compounding, Inc. is recalling Methylcobalamin Injection 5 mg/mL, For IM or SC Administration, Sterile 30 mL Multiple Dose Vials. The recall is being conducted due to a lack of assurance of sterility for the product.
The affected product is identified as Lot #06132013@1 with an expiration date of 12/10/2013. A total of 297 vials were distributed to locations in California and Indiana. The recall notice also references Park Compounding and other injectable products, but the specific product details provided pertain to the Methylcobalamin Injection.
Consumers and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions on disposal or replacement.
The recalled product
- Product
- Methylcobalamin Injection 5 mg/mL, For IM or SC Administration, Sterile 30 mL Multiple Dose Vial, Park Compounding, Irvine, CA
- Manufacturer
- South Coast Specialty Compounding, Inc.
- Category
- Drug — Injectable Medication
- Affected units
- 297
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #06132013@1
- Exp 12/10/2013
Distribution
Part of a larger recall action
This product is one of 3 recalled by South Coast Specialty Compounding, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · South Coast Specialty Compounding, Inc.
See all →- SevereMethyl Folate Injection Recalled Due to Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- SevereMeloxicam Capsules Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- HighArtesunate Injection Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- SevereLeucovorin Calcium Capsules Recalled for Potential Penicillin Contamination
FDA (Drugs) · 2015-09-09
- SevereSouth Coast Specialty Compounding Recalls Tri-Est 80:10:10 Capsules
FDA (Drugs) · 2015-09-09
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePark Compounding Pharmacy Recalls Methylcobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereUS Compounding Recalls Methylcobalamin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereMethylcobalamin Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- Severe
- SevereMethylcobalamin Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereInnovative Compounding Pharmacy Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2020-04-15